Form 8-K - Current report:
SEC Accession No. 0001144204-15-070350
Filing Date
2015-12-10
Accepted
2015-12-10 17:00:30
Documents
4
Period of Report
2015-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v426642_8-k.htm 8-K 23753
2 EXHIBIT 10.1 v426642_ex10-1.htm EX-10.1 9633
3 EXHIBIT 10.2 v426642_ex10-2.htm EX-10.2 58412
4 GRAPHIC image_001.jpg GRAPHIC 2532
  Complete submission text file 0001144204-15-070350.txt   97024
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 151281452
SIC: 2834 Pharmaceutical Preparations